SAPINO, Anna
 Distribuzione geografica
Continente #
NA - Nord America 17.320
EU - Europa 11.355
AS - Asia 5.484
OC - Oceania 170
AF - Africa 165
SA - Sud America 163
Continente sconosciuto - Info sul continente non disponibili 20
Totale 34.677
Nazione #
US - Stati Uniti d'America 16.951
CN - Cina 3.490
IT - Italia 2.849
IE - Irlanda 1.395
SE - Svezia 1.157
DE - Germania 1.098
FR - Francia 897
GB - Regno Unito 807
UA - Ucraina 755
FI - Finlandia 673
KR - Corea 506
AT - Austria 423
PL - Polonia 409
VN - Vietnam 374
CA - Canada 326
JP - Giappone 274
IN - India 266
ES - Italia 178
AU - Australia 162
NL - Olanda 145
BE - Belgio 112
DK - Danimarca 103
TR - Turchia 92
HK - Hong Kong 89
SG - Singapore 88
BR - Brasile 83
SN - Senegal 74
CH - Svizzera 62
TW - Taiwan 61
TH - Thailandia 55
RU - Federazione Russa 45
RO - Romania 42
IR - Iran 37
MX - Messico 36
PT - Portogallo 33
NO - Norvegia 29
IL - Israele 28
GR - Grecia 26
ID - Indonesia 25
HU - Ungheria 24
UZ - Uzbekistan 24
CO - Colombia 23
NG - Nigeria 21
EG - Egitto 19
CL - Cile 18
CZ - Repubblica Ceca 16
PE - Perù 15
SA - Arabia Saudita 14
EU - Europa 13
AR - Argentina 12
MK - Macedonia 11
TN - Tunisia 10
BA - Bosnia-Erzegovina 9
BG - Bulgaria 9
ZA - Sudafrica 9
HR - Croazia 8
MU - Mauritius 8
NZ - Nuova Zelanda 8
BY - Bielorussia 7
MY - Malesia 7
PH - Filippine 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
MO - Macao, regione amministrativa speciale della Cina 6
RS - Serbia 6
SI - Slovenia 6
CR - Costa Rica 5
EE - Estonia 5
JO - Giordania 5
KE - Kenya 5
KW - Kuwait 5
PK - Pakistan 5
SD - Sudan 5
AP - ???statistics.table.value.countryCode.AP??? 4
EC - Ecuador 4
A1 - Anonimo 3
AM - Armenia 3
GH - Ghana 3
LT - Lituania 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BD - Bangladesh 2
BO - Bolivia 2
IQ - Iraq 2
IS - Islanda 2
PY - Paraguay 2
TZ - Tanzania 2
UY - Uruguay 2
VE - Venezuela 2
BH - Bahrain 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 34.672
Città #
Chandler 2.061
Beijing 1.763
Dublin 1.339
Fairfield 1.291
Ann Arbor 1.156
Houston 1.074
Ashburn 847
Woodbridge 664
Torino 647
Dearborn 598
Wilmington 562
Jacksonville 556
Seattle 508
Villeurbanne 493
Medford 463
Cambridge 425
Princeton 413
Vienna 404
Nyköping 397
Warsaw 358
Pisa 313
Redwood City 250
Dong Ket 219
Milan 218
Shanghai 173
Menlo Park 152
Guangzhou 146
Fremont 142
Toronto 139
Turin 134
Boston 133
Nanjing 121
New York 119
Boardman 114
Hangzhou 114
San Diego 90
Verona 85
London 72
Hefei 71
Tokyo 66
Norwalk 65
Brussels 61
Munich 61
Pune 61
Chengdu 60
Jinan 60
Rome 57
Phoenix 53
Kunming 51
Washington 51
Wuhan 51
Helsinki 50
Chicago 45
Falls Church 44
Los Angeles 43
Zhengzhou 43
Lachine 41
Nanchang 37
Fuzhou 36
Mountain View 35
Seoul 34
Changsha 33
Silver Spring 33
Tappahannock 32
Upper Marlboro 32
Taipei 31
Shenyang 30
Xian 30
Hong Kong 29
Chongqing 28
Paris 28
Singapore 28
Amsterdam 27
Genoa 26
Hebei 26
Nürnberg 25
Sydney 25
Bangkok 24
Ottawa 24
Dallas 23
Düsseldorf 23
Carrara 21
Delhi 21
Santa Cruz 21
Hyderabad 20
Madrid 20
Moncalieri 20
Provo 20
Bengaluru 19
Bologna 19
Lappeenranta 19
Barcelona 18
Buffalo 18
Detroit 18
Istanbul 18
Napoli 18
Changchun 17
Duncan 17
Guiyang 17
Montréal 17
Totale 20.844
Nome #
PARP Inhibitors in Ovarian Cancer 2.430
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 640
Beneficial behavioural effects of IBD therapy and gluten/casein-free diet in an Italian cohort of patients with autistic enterocolitis followed over one year 575
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 572
Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients 448
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values 347
MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue 333
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 303
Reliability of Whole Sentinel Lymph Node Analysis by One-Step Nucleic Acid Amplification for Intraoperative Diagnosis of Breast Cancer Metastases 290
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 275
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 262
Abstract P6-08-12: DSCAM-AS1, a breast cancer specific and Estrogen receptor α-dependent long noncoding RNA, is a key component of the pathway controlling cell growth and migration 251
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. 248
Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples 242
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. 232
Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. 231
Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study 226
SF3B1mutations constitute a novel therapeutic target in breast cancer 222
Comparison of Anti-Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer: Lower 1D5 Sensitivity but Questionable Clinical Implications 218
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 218
A "Weighted" Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors. 215
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 208
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer 207
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 205
Personalized therapeutic strategies in HER2-driven gastric cancer 204
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 203
The diagnosis of inflammatory bowel disease is often unsupported in clinical practice 197
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling 197
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 195
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis 195
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 186
Oxytocin synthesis within the normal and neoplastic breast: first evidence of a local peptide source 182
Androgen receptor status predicts development of brain metastases in ovarian cancers 182
HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast 174
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 173
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 170
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 169
The expression of growth hormone releasing hormone (GHRH) and its receptors in breast carcinomas with apocrine differentiation - further evidence of the presence of a GHRH pathway in these tumors 164
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 163
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues 161
miR-221/222 control luminal breast cancer tumor progression by regulating different targets 158
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes 158
FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients 158
The influence of tissue ischemia time on RNA integrity and patient-derived xenografts (PDX) engraftment rate in a non-small cell lung cancer (NSCLC) Biobank 157
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis 156
Tamoxifen treatment of breast cancer cells: Impact on Hedgehog/GLI1 signaling 156
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 156
Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up? 155
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond 155
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. 149
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer 149
Meningeal carcinomatosis underdiagnosis and overestimation: Incidence in a large consecutive and unselected population of breast cancer patients 144
Glycerolized reticular dermis as a new human acellular dermal matrix: An exploratory study 138
A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study 138
Pleomorphism of the Nuclear Envelope in breast cancer: a new approach to an old problem 137
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 137
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS 135
The perfect pathology report after neoadjuvant therapy 135
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues 134
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue 134
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 133
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells. 132
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 132
Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses 131
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 131
A rare case of breast cancer showing distinct TTF-1 nuclear expression: small cell carcinoma or not? 131
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 131
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 129
Colesterolo ossidato e induzione del recettore scavenger CD36 128
The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients 128
“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer 127
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study 124
Efficiency of a Preoperative Axillary Ultrasound and Fine-Needle Aspiration Cytology to Detect Patients with Extensive Axillary Lymph Node Involvement 123
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 119
A simple and reproducible prognostic index in luminal ER-positive breast cancers. 118
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 117
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 117
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 116
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 116
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort 115
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene 114
Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres 111
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples 111
ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules 111
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage 111
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling 111
Two new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations identified in a cohort of Italian breast and ovarian cancer families. 110
Formalin fixation at low temperature better preserves nucleic acid integrity. 109
Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma. 107
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 107
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 106
Sviluppo pre-clinico di una nuova matrice dermica acellulare di derivazione umana per la ricostruzione mammaria post oncologica 106
Neutralization of IL-10 And TGF beta 1 rescues T cells from tolerogenic mechanisms induced by HER2 vaccine in cancer patients 106
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization 105
Contrast enhanced ultrasound in atherosclerotic carotid artery disease. 104
Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method 104
[Tumor samples as a tool for large-scale monitoring of antigen-specific lymphocytes in gastric and colorectal neoplasms] 104
Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. 104
DNA vaccines coding for chimeric human/rat HER2 as innovative immunotherapeutic tools for the treatment of HER2+ cancer patients 103
Il carcinoma in situ micropapillare della mammella. Correlazioni anatomo-patologiche e cliniche 103
Totale 19.897
Categoria #
all - tutte 90.333
article - articoli 0
book - libri 0
conference - conferenze 6.107
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.260 0 0 0 0 0 0 0 0 0 0 859 401
2019/20205.597 265 260 317 608 471 1.065 655 416 545 412 345 238
2020/20214.904 316 282 418 333 388 335 482 303 524 484 317 722
2021/20225.443 292 309 319 441 316 311 444 388 260 354 1.000 1.009
2022/20236.748 686 549 207 560 649 1.575 540 476 715 182 371 238
2023/20242.886 422 580 217 245 255 402 179 245 56 270 15 0
Totale 35.858